Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)

NCT04018482 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-03-10

No results posted yet for this study

Summary

To compare the efficacy and comfort of two FDA approved pre-injection antiseptics when used for intravitreal injections.

Conditions

Interventions

OTHER

Povidone Iodine

FDA-approved disinfectant for intravitreal injections

OTHER

Hypochlorous Acid

FDA-approved disinfectant for intravitreal injections

Sponsors & Collaborators

  • California Retina Consultants

    lead OTHER

Principal Investigators

  • Robert Avery, MD · California Retina Consultants

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-16
Primary Completion
2019-08-14
Completion
2019-08-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018482 on ClinicalTrials.gov